Previous studies report Alzheimer’s disease-associated soluble epoxide hydrolase upregulation in the brain and that endocannabinoid metabolism provides an adaptive response to neuroinflammation. Here, EPHX2 is linked to early-onset autosomal dominant Alzheimer disease.